{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:45Z","timestamp":1792294485997,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK122280"],"award-info":[{"award-number":["R01-DK122280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cgh.2023.07.031","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T02:12:53Z","timestamp":1694225573000},"page":"3217-3229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cannabinoids and the Gastrointestinal Tract"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7514","authenticated-orcid":false,"given":"Michael","family":"Camilleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.07.031_bib2","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.07.031_bib3","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110","article-title":"Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis","volume":"125","author":"Meng","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cgh.2023.07.031_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A\u00a0systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cgh.2023.07.031_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","article-title":"Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health","volume":"8","author":"Weinstein","year":"2017","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.cgh.2023.07.031_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2017.07.005","article-title":"Unintentional cannabis ingestion in children: a systematic review","volume":"190","author":"Richards","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2023.07.031_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.08.014","article-title":"Cannabis use during pregnancy: pharmacokinetics and effects on child development","volume":"182","author":"Grant","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.07.031_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.cgh.2023.07.031_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13370","article-title":"Cannabinoids and gastrointestinal motility: pharmacology, clinical effects, and potential therapeutics in humans","volume":"30","author":"Camilleri","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib12","doi-asserted-by":"crossref","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","article-title":"Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats","volume":"295","author":"Duncan","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.07.031_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bjp.0706710","article-title":"Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon","volume":"148","author":"Hinds","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib17","first-page":"G655","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.cgh.2020.04.020","article-title":"Pharmacology, clinical effects, and therapeutic potential of cannabinoids for gastrointestinal and liver diseases","volume":"19","author":"Maselli","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818783908","article-title":"Cannabinoid ligands, receptors and enzymes: pharmacological tools and therapeutic potential","volume":"2","author":"Hourani","year":"2018","journal-title":"Brain Neurosc Adv"},{"key":"10.1016\/j.cgh.2023.07.031_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.11.005","article-title":"Human presynaptic receptors","volume":"172","author":"Schlicker","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/nmo.12931","article-title":"The gastrointestinal tract \u2013 a central organ of cannabinoid signaling in health and disease","volume":"28","author":"Hasenoehrl","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gut.2008.148791","article-title":"Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects","volume":"57","author":"Izzo","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.07.031_bib24","doi-asserted-by":"crossref","first-page":"G254","DOI":"10.1152\/ajpgi.00186.2019","article-title":"Acute regulation\u00a0of intestinal ion transport and permeability in response to luminal nutrients: the role of the enteric nervous system","volume":"318","author":"Cavin","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib25","doi-asserted-by":"crossref","first-page":"G219","DOI":"10.1152\/ajpgi.00341.2021","article-title":"Role of CB 1 receptors in the acute regulation of small intestinal permeability: effects of high-fat diet","volume":"323","author":"Cuddihey","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain-gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.07.031_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2020.03.087","article-title":"Role of cannabis and its derivatives in gastrointestinal and hepatic disease","volume":"159","author":"Gotfried","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.07.031_bib28","article-title":"Cannabis liberalization in the US: the\u00a0policy landscape","author":"Haffajee","year":"2021","journal-title":"Health Affairs Health Policy Brief"},{"key":"10.1016\/j.cgh.2023.07.031_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15563650.2023.2177552","article-title":"Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization","volume":"61","author":"Tolan","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.cgh.2023.07.031_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2023.107723","article-title":"Treatment outcomes among pregnant women with cannabis use disorder","volume":"144","author":"Kitsantas","year":"2023","journal-title":"Addict Behav"},{"key":"10.1016\/j.cgh.2023.07.031_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104039","article-title":"The impact of legal cannabis availability on cannabis use and health outcomes: a systematic review","volume":"116","author":"Manthey","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.cgh.2023.07.031_bib33","article-title":"Racial\/ethnic discrimination and tobacco and cannabis use outcomes among US adults","volume":"148","author":"Mattingly","year":"2023","journal-title":"J\u00a0Subst Use Addict Treat"},{"key":"10.1016\/j.cgh.2023.07.031_bib34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/10826084.2023.2188427","article-title":"Substance use in U.S. Vietnam war era veterans and nonveterans: results from the Vietnam Era Health Retrospective Observational Study","volume":"58","author":"Cypel","year":"2023","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.cgh.2023.07.031_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/10826084.2023.2191700","article-title":"National trends in past-year marijuana use among veterans in the United States, 2013-2019","volume":"58","author":"Yockey","year":"2023","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.cgh.2023.07.031_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12888-023-04648-5","article-title":"A\u00a0national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care","volume":"23","author":"Zaman","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cgh.2023.07.031_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad031","article-title":"Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021","volume":"7","author":"Sarkar","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.cgh.2023.07.031_bib38","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.3390\/ijerph20065129","article-title":"A\u00a0survey of cannabis use among patients with inflammatory bowel disease (IBD)","volume":"20","author":"Velez-Santiago","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cgh.2023.07.031_bib39","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10620-019-05963-2","article-title":"Marijuana use in patients with symptoms of gastroparesis: prevalence, patient characteristics, and perceived benefit","volume":"65","author":"Parkman","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.07.031_bib40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/MCG.0000000000001295","article-title":"Factors associated with hospital admissions and readmissions in patients with gastroparesis using the nationwide readmission database","volume":"54","author":"Shahsavari","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib41","article-title":"Marijuana use in patients with gastroparesis","author":"Saleem","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.cgh.2023.07.031_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/00325481.2021.1940219","article-title":"Gastroparesis with cannabis use: a retrospective study from the Nationwide Inpatient Sample","volume":"133","author":"Dahiya","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.cgh.2023.07.031_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jgh.12346","article-title":"Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation","volume":"29","author":"Zhang","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib44","first-page":"332","article-title":"Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice","volume":"66","author":"Lin","year":"2014","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.cgh.2023.07.031_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2982.2006.00834.x","article-title":"Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study","volume":"18","author":"Esfandyari","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib46","first-page":"137","article-title":"Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study","volume":"293","author":"Esfandyari","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib47","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjp.0705783","article-title":"Involvement of cannabinoid receptors in gut motility and visceral perception","volume":"141","author":"Hornby","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib48","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/bph.13114","article-title":"Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation","volume":"172","author":"Bashashati","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell","volume":"39","author":"Juan-Pic\u00f3","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.cgh.2023.07.031_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029822","article-title":"Acute pancreatitis as a rare adverse event among cannabis users: a systematic review","volume":"101","author":"Jaiswal","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2023.07.031_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40264-022-01146-7","article-title":"Cannabinoid-related acute pancreatitis: an update from international literature and individual case safety reports","volume":"45","author":"Azam","year":"2022","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2023.07.031_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.annepidem.2010.01.003","article-title":"Associations between duration of illicit drug use and health conditions: results from the 2005\u20132007 national surveys on drug use and health","volume":"20","author":"Han","year":"2010","journal-title":"Ann Epidemiol"},{"issue":"Suppl 5","key":"10.1016\/j.cgh.2023.07.031_bib53","first-page":"137","article-title":"Cannabinoids in acute gastric damage and pancreatitis","volume":"57","author":"Dembi\u0144ski","year":"2006","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib54","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1053\/j.gastro.2007.02.035","article-title":"Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis","volume":"132","author":"Michalski","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.07.031_bib55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2017.00014","article-title":"Modulation of human peripheral blood mononuclear cell signaling by medicinal cannabinoids","volume":"10","author":"Utomo","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cgh.2023.07.031_bib56","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ajg.2015.197","article-title":"Cannabinoid receptor agonist Namisol does not affect cytokine levels in chronic pancreatitis patients","volume":"110","author":"Utomo","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib57","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cgh.2016.09.147","article-title":"Tetrahydrocannabinol does not reduce pain in patients with chronic abdominal pain in a phase 2 placebo-controlled study","volume":"15","author":"de Vries","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib58","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.cgh.2019.01.018","article-title":"Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis","volume":"17","author":"Barlowe","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/acer.13929","article-title":"Reduced risk of alcohol-induced pancreatitis with cannabis use","volume":"43","author":"Adejumo","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2023.07.031_bib60","first-page":"1","article-title":"Potential use of cannabinoids for the treatment of pancreatic cancer","volume":"5","author":"Sharafi","year":"2019","journal-title":"J\u00a0Pancreat Cancer"},{"key":"10.1016\/j.cgh.2023.07.031_bib61","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.3390\/cancers12102774","article-title":"Cannabidiol and oxygen-ozone combination induce cytotoxicity in human pancreatic ductal adenocarcinoma cell lines","volume":"12","author":"Luongo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cgh.2023.07.031_bib62","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/molecules27041214","article-title":"Cannabis sativa extract induces apoptosis in human pancreatic 3D cancer models: importance of major antioxidant molecules present therein","volume":"27","author":"Emhemmed","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cgh.2023.07.031_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2826.2008.01679.x","article-title":"The endocannabinoid system and liver diseases","volume":"20","author":"Caraceni","year":"2008","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.cgh.2023.07.031_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41575-019-0233-8","article-title":"Hepatocyte-stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids","volume":"17","author":"Argemi","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate signaling in hepatic stellate cells drives alcoholic steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.cgh.2023.07.031_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.697832","article-title":"A\u00a0novel mechanism of cannabidiol in suppressing hepatocellular carcinoma by inducing GSDME dependent pyroptosis","volume":"9","author":"Shangguan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cgh.2023.07.031_bib67","doi-asserted-by":"crossref","first-page":"9423","DOI":"10.3390\/ijms23169423","article-title":"Cannabinoids and chronic liver diseases","volume":"23","author":"Mboumba Bouassa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2023.07.031_bib68","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms20102516","article-title":"Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis","volume":"20","author":"Bazwinsky-Wutschke","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2023.07.031_bib69","first-page":"52","article-title":"The role of cannabinoids in the setting of cirrhosis","volume":"5","author":"Dibba","year":"2018","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.cgh.2023.07.031_bib70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2017.03.008","article-title":"Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B","volume":"59","author":"Dai","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cgh.2023.07.031_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C","volume":"42","author":"H\u00e9zode","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.07.031_bib72","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2119\/molmed.2011.00149","article-title":"Cannabinoid receptor type I modulates alcohol-induced liver fibrosis","volume":"17","author":"Patsenker","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.cgh.2023.07.031_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012841","article-title":"Hepatitis C virus\u00a0induces the cannabinoid receptor 1","volume":"5","author":"van der Poorten","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2023.07.031_bib74","article-title":"Analytic cannabis effect on hepatic steatosis and hepatic fibrosis: a meta-analytic evaluation","author":"Gangwani","year":"2023","journal-title":"Am J Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.981817","article-title":"Cannabidiol markedly alleviates skin and liver fibrosis","volume":"13","author":"Del R\u00edo","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cgh.2023.07.031_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0083-6729(09)81019-4","article-title":"Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis","volume":"81","author":"Pandey","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1016\/j.cgh.2023.07.031_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.10.008","article-title":"Cannabis use may\u00a0reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis","volume":"23","author":"Sobotka","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13174","article-title":"Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic","volume":"30","author":"Sagar","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib79","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2019.07.039","article-title":"Patterns of cannabis use in patients with cyclic vomiting syndrome","volume":"18","author":"Venkatesan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib80","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.14309\/ajg.0000000000002216","article-title":"Diagnosis and management of cyclic vomiting syndrome: a critical review","volume":"118","author":"Frazier","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib81","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cgh.2018.05.020","article-title":"Epidemiology, clinical characteristics, and associations for Rome IV functional nausea and vomiting disorders in adults","volume":"17","author":"Aziz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib82","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00221-014-3967-0","article-title":"An internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)","volume":"232","author":"Venkatesan","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.cgh.2023.07.031_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mayocp.2011.10.005","article-title":"Cannabinoid hyperemesis: a case series of 98 patients","volume":"87","author":"Simonetto","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2023.07.031_bib84","article-title":"Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome","volume":"31","author":"Venkatesan","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib85","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/apt.17265","article-title":"Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence","volume":"56","author":"Andrews","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib86","article-title":"Rising inpatient utilization and costs of cannabis hyperemesis syndrome hospitalizations in Massachusetts after cannabis legalization","author":"Marshall","year":"2023","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib87","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/phar.1931","article-title":"Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review","volume":"37","author":"Richards","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cgh.2023.07.031_bib88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/apt.12822","article-title":"Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome","volume":"40","author":"Cristofori","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib89","article-title":"Emerging role of aprepitant in cannabis hyperemesis syndrome","volume":"11","author":"Parvataneni","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2023.07.031_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2011.11.007","article-title":"Diagnostic criteria for cannabis withdrawal syndrome","volume":"123","author":"Gorelick","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cgh.2023.07.031_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12245-022-00446-0","article-title":"Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department","volume":"15","author":"Razban","year":"2022","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.cgh.2023.07.031_bib92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2018.12.009","article-title":"Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016","volume":"196","author":"Young-Wolff","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cgh.2023.07.031_bib93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/AOG.0000000000004850","article-title":"Association of cannabis use with nausea and vomiting of pregnancy","volume":"140","author":"Metz","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cgh.2023.07.031_bib94","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/AOG.0000000000002878","article-title":"Marijuana use in pregnancy and while breastfeeding","volume":"132","author":"Metz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cgh.2023.07.031_bib95","article-title":"Addressing cannabis consumption among patients with hyperemesis gravidarum","volume":"3","author":"Galvin","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.cgh.2023.07.031_bib96","article-title":"The use of cannabis and its effects on postpartum depression","volume":"14","author":"Ayisire","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2023.07.031_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.1999.00441.x","article-title":"Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study","volume":"13","author":"McCallum","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib98","article-title":"Impact of cannabinoids on symptoms of refractory gastroparesis: a single-center experience","volume":"11","author":"Barbash","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2023.07.031_bib99","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","article-title":"Cannabis, cannabinoids, and the endocannabinoid system - is there therapeutic potential for inflammatory bowel disease?","volume":"13","author":"Ambrose","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2023.07.031_bib100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2023.07.031_bib101","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ibd\/izz017","article-title":"Palmitoylethanolamide and cannabidiol prevent inflammation-induced hyperpermeability of the human gut in\u00a0vitro and in\u00a0vivo - a randomized, placebo-controlled, double-blind controlled trial","volume":"25","author":"Couch","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.07.031_bib102","first-page":"G364","article-title":"Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium","volume":"291","author":"Kimball","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2023.07.031_bib103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","article-title":"Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation","volume":"20","author":"D\u2019Argenio","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.cgh.2023.07.031_bib104","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-2982.2006.00819.x","article-title":"Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats","volume":"18","author":"Sanson","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cgh.2023.07.031_bib106","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease\u00a0but is associated with worse disease prognosis in patients with Crohn's disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.07.031_bib107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17474124.2022.2161046","article-title":"The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry","volume":"17","author":"Dalavaye","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib108","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib109","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.07.031_bib110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A\u00a0randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.07.031_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246871","article-title":"Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial","volume":"16","author":"Naftali","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2023.07.031_bib112","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","article-title":"Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn\u2019s disease, a randomized controlled trial","volume":"15","author":"Naftali","year":"2021","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.cgh.2023.07.031_bib113","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MCG.0000000000001393","article-title":"Systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies?","volume":"55","author":"Doeve","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib114","article-title":"Safety, pharmacokinetics, and efficacy of olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, in a phase 2a study of patients with chronic abdominal pain associated with Crohn's disease","volume":"3","author":"Yacyshyn","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.cgh.2023.07.031_bib115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41575-022-00682-y","article-title":"Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome","volume":"20","author":"Brierley","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.07.031_bib116","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.07.031_bib117","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1053\/j.gastro.2019.01.215","article-title":"Olorinab, a peripherally restricted, highly selective agonist of the cannabinoid receptor type 2 for the management of visceral pain in inflammatory bowel disease (IBD)\u2014preclinical and early clinical development","volume":"156","author":"Lindstrom","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.07.031_bib118","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/j.pain.0000000000002314","article-title":"Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents","volume":"163","author":"Castro","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2023.07.031_bib119","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14539","article-title":"Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)","volume":"35","author":"Chang","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2023.07.031_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.cgh.2023.07.031_bib121","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.14309\/ajg.0000000000001805","article-title":"Cannabidiol for functional dyspepsia with normal gastric emptying: a randomized controlled trial","volume":"117","author":"Atieh","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.07.031_bib122","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/can.2020.0087","article-title":"Effects of cannabidiol chewing gum on perceived pain and well-being of irritable bowel syndrome patients: a placebo-controlled crossover exploratory intervention study with symptom-driven dosing","volume":"7","author":"van Orten-Luiten","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.cgh.2023.07.031_bib123","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.cgh.2023.07.008","article-title":"A\u00a0randomized, controlled trial of efficacy and safety of cannabidiol in idiopathic and diabetic gastroparesis","volume":"21","author":"Zheng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523006687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523006687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:41:15Z","timestamp":1761543675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523006687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":120,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1542356523006687"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.07.031","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids and the Gastrointestinal Tract","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}